You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 22

November-2 2021 - 279 articles

Cover Story: Recurrent mutations in the N-terminal tail of histones H3.3 and H3.1 act as key biological drivers of pediatric high-grade glioma (pHGG), leading to distinct epigenetic reprogramming, telomere maintenance mechanisms and oncogenesis scenarios, and defining pHGG subgroups. Notably, mutations in H3.3 are frequently associated with mutations affecting the H3.3 chaperone complex ATRX/DAXX. How the (epi)genetic alterations defining each pHGG subgroup provide novel therapeutic opportunities remains a challenge. Pinto et al. summarize the DNA repair pathways that drive resistance to current therapeutic strategies in pHGGs and review the functions of H3.3 and its chaperones in chromatin dynamics and DNA repair. They then discuss potential strategies targeting DNA repair and telomere maintenance mechanisms to improve the treatment of pHGG. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (279)

  • Review
  • Open Access
79 Citations
20,822 Views
19 Pages

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

  • Jenneke C. Kasius,
  • Johanna M. A. Pijnenborg,
  • Kristina Lindemann,
  • David Forsse,
  • Judith van Zwol,
  • Gunnar B. Kristensen,
  • Camilla Krakstad,
  • Henrica M. J. Werner and
  • Frédéric Amant

22 November 2021

Endometrial cancer (EC) is the most common gynaecologic malignancy in developed countries. The main challenge in EC management is to correctly estimate the risk of metastases at diagnosis and the risk to develop recurrences in the future. Risk strati...

  • Article
  • Open Access
11 Citations
2,720 Views
10 Pages

Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAFV600E-Mutant Advanced Papillary Thyroid Carcinoma

  • Eyun Song,
  • Meihua Jin,
  • Ahreum Jang,
  • Min Ji Jeon,
  • Dong Eun Song,
  • Hye Jin Yoo,
  • Won Bae Kim,
  • Young Kee Shong and
  • Won Gu Kim

22 November 2021

The prognosis of BRAFV600E-mutant papillary thyroid carcinoma (PTC) ranges from indolent to highly aggressive courses. To better define the genetic diversity of this subtype, we evaluated the survival according to the presence of an additional mutati...

  • Review
  • Open Access
26 Citations
6,499 Views
31 Pages

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches

  • Karam Khaddour,
  • Lucas Maahs,
  • Ana Maria Avila-Rodriguez,
  • Yazan Maamar,
  • Sami Samaan and
  • George Ansstas

22 November 2021

Melanomas exhibit the highest rate of somatic mutations among all different types of cancers (with the exception of BCC and SCC). The accumulation of a multimode of mutations in the driver oncogenes are responsible for the proliferative, invasive, an...

  • Article
  • Open Access
10 Citations
3,217 Views
21 Pages

AKF-D52, a Synthetic Phenoxypyrimidine-Urea Derivative, Triggers Extrinsic/Intrinsic Apoptosis and Cytoprotective Autophagy in Human Non-Small Cell Lung Cancer Cells

  • Hyo-Sun Gil,
  • Jeong-Hun Lee,
  • Ahmed K. Farag,
  • Ahmed H. E. Hassan,
  • Kyung-Sook Chung,
  • Jung-Hye Choi,
  • Eun-Joo Roh and
  • Kyung-Tae Lee

22 November 2021

Previously, we discovered that 1-(3,5-dimethoxyphenyl)-3-(4-(3-methoxyphenoxy)-2-((4-morpholinophenyl)amino)pyrimidin-5-yl)urea (AKF-D52), a synthetic phenoxypyrimidine urea derivative, acts as a growth inhibitor of various cancer cell types. In this...

  • Article
  • Open Access
5 Citations
3,970 Views
10 Pages

Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?

  • Nicole Tubiana-Mathieu,
  • Thibault Cornette,
  • Stephane Mandigout,
  • Sophie Leobon,
  • François Vincent,
  • Laurence Venat and
  • Elise Deluche

22 November 2021

Background: Adapted physical activity (APA) aids breast cancer patients. It is necessary to use an adapted target heart rate (HR) when prescribing exercise intensity. Methods: In total, 138 patients previously included in two published randomized cli...

  • Article
  • Open Access
35 Citations
3,327 Views
18 Pages

22 November 2021

Research on the relationship between the geriatric nutritional risk index (GNRI) and postoperative complications/oncological outcomes in elderly colorectal cancer (CRC) patients is limited. This study investigated the prognostic value of the GNRI in...

  • Review
  • Open Access
4 Citations
5,096 Views
22 Pages

An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features

  • Ahmed Ebada Salem,
  • Yehia H. Zaki,
  • Gamal El-Hussieny,
  • Khaled I. ElNoueam,
  • Akram M. Shaaban,
  • Bhasker Rao Koppula,
  • Mark Bustoros,
  • Mohamed Salama,
  • Khaled M. Elsayes and
  • Kathryn Morton
  • + 1 author

22 November 2021

Lymphoproliferative disorders (LPD) are conditions characterized by the uncontrolled proliferation of B or T-cell lines. They encompass a wide spectrum of abnormalities, which may be broadly classified as reactive processes or malignant diseases, suc...

  • Article
  • Open Access
6 Citations
3,482 Views
15 Pages

miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles

  • Andrew Chin,
  • Javier Mariscal,
  • Minhyung Kim,
  • Giorgia Guerra,
  • Blandine Victor,
  • Chen Qian,
  • Elisabetta Broseghini,
  • Edwin Posadas,
  • Michael R. Freeman and
  • Shivani Sharma
  • + 7 authors

22 November 2021

Cancer cells shed a heterogenous mixture of extracellular vesicles (EVs), differing in both size and composition, which likely influence physiological processes in different manners. However, how cells differentially control the shedding of these EV...

  • Article
  • Open Access
12 Citations
2,858 Views
14 Pages

Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides

  • Cosimo Di Raimondo,
  • Zhen Han,
  • Chingyu Su,
  • Xiwei Wu,
  • Hanjun Qin,
  • James F. Sanchez,
  • Yate-Ching Yuan,
  • Xochiquetzal Martinez,
  • Farah Abdulla and
  • Jasmine Zain
  • + 3 authors

22 November 2021

Large cell transformation of mycosis fungoides (LCT-MF) occurs in 20–50% of advanced MF and is generally associated with poor response and dismal prognosis. Although different mechanisms have been proposed to explain the pathogenesis, little is...

  • Review
  • Open Access
58 Citations
6,861 Views
26 Pages

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma

  • Myung-Chul Kim,
  • Zeng Jin,
  • Ryan Kolb,
  • Nicholas Borcherding,
  • Jonathan Alexander Chatzkel,
  • Sara Moscovita Falzarano and
  • Weizhou Zhang

22 November 2021

Several clinicopathological features of clear cell renal cell carcinomas (ccRCC) contribute to make an “atypical” cancer, including resistance to chemotherapy, sensitivity to anti-angiogenesis therapy and ICIs despite a low mutational bur...

of 28

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694